Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02464696Recruiting
Randomised, open-label trial (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Percent of patients who require intubation or meet criteria for intubation at 28 days. Started Oct 2015; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02464696.